Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of arsenic trioxide (Oral-ATO; ARSENOL) for the treatment of acute promyelocytic leukemia (APL), a blood cancer that once had a high fatality rate.
Innovative protein hydrogel shows potential for targeted drug delivery
A research team, affiliated with UNIST has unveiled soft self-standing protein hydrogels that selectively deliver drugs, thereby enhancing medicinal effects while minimizing associated toxicity.
New blood-clotting disorder identified
Researchers at McMaster University have made a discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with full-dose blood thinners.
Curcumin in Traditional Chinese medicine: Study show how it regulates neuroinflammation after epileptic seizures
A new study published in Advanced Science has revealed how curcumin, a bioactive compound found in Curcuma aromatica (Yujin), can help mitigate neuroinflammation and brain damage caused by epileptic seizures.
MAGE-A4 protein promotes tumor progression by suppressing immune responses, mouse study finds
A study published in Science Advances reveals a novel strategy that allows tumors to evade the body’s immune response critical for their elimination. Researchers at Baylor College of Medicine and collaborating institutions have discovered in a mouse model of non-small cell lung cancer that tumors that express protein MAGE-A4 and have lost the Pten gene, a tumor suppressor, accelerate their development and progression into metastasis.
Vitamin E succinate shown to control tumor growth and enhance immunotherapy effects
High levels of fat mass and obesity-associated protein (FTO) have been linked to increased tumor growth and resistance to immunotherapy. In a study recently published in the Proceedings of the National Academy of Sciences, researchers from the University of Chicago Medicine have identified vitamin E succinate (VES) as an effective agent in controlling tumor growth by promoting the degradation of FTO.
New study finds lower cardiovascular risk in type 1 diabetes than in type 2 diabetes
A new study published in the Journal of the Society for Cardiovascular Angiography & Interventions has revealed a lower risk of cardiovascular events for patients with type 1 diabetes (often called juvenile diabetes) than for those with type 2 diabetes. The research highlights the differences between the two types of diabetes and provides new insights that could influence future treatment approaches.
Simple, quick test can predict fall risk in older adults six months in advance
The scenario is common. An elderly person seems to be in good health until one day they suffer a fall, and from then on their quality of life begins to deteriorate. Even if there are no serious consequences such as injuries, fractures or head trauma, falls usually lead to reduced mobility and consequently to a loss of independence and autonomy.
New research uncovers brain changes in Parkinson’s disease
Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson’s disease using advanced imaging techniques.
Parental consent law change reduces abortion delays and improves access in Massachusetts
Individuals below the age of 18 are faced with significant barriers when receiving abortion care due to additional parental consent requirements. To address this, the 2020 ROE Act in Massachusetts removed these requirements for minors aged 16–17 years. A new study reveals that this policy change led to a ~60-day decrease in gestational duration at abortion among this age group, highlighting the importance and impact of decreasing barriers to abortion access for minors.